Clinical trial Recruiting at 1 site Observational Ages 40 to 75

Lifestyle Metabotype Study: How Daily Habits Shape Blood Sugar

Official title: LIfestyle MEtabotype Study (Module A)

Run by German Institute of Human Nutrition · NCT07868601 · Data updated 2026-11-12

This observational study tests whether personal lifestyle and biological factors can predict how a person’s blood sugar responds after meals.

Quick facts

Study typeObservational
Ages40 Years to 75 Years
SexAll
Enrollment300 (estimated)
SponsorGerman Institute of Human Nutrition
Academic / other
Locations1 site (Potsdam, Potsdam-Rehbrücke)
StatusRecruiting
StartedOctober 10, 2026
Main results expectedDecember 31, 2030
Study endsDecember 31, 2031
Registry record updatedOctober 9, 2026
Trial IDNCT07868601 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults with overweight or obesity (BMI 25-40 kg/m²) who have good knowledge of German and are in varying glycemic statuses (prediabetes, type 2 diabetes, or without these conditions).

Probably not a fit

Individuals outside the BMI range, non-German speakers, or those with unstable medical conditions or recent significant weight changes may have limited relevance to the study findings.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The study aims to identify lifestyle, metabolic, molecular, and neurocognitive factors that predict individual postprandial glucose fluctuations across people with prediabetes, type 2 diabetes, and those without these conditions. Participants undergo comprehensive phenotyping in the center and are monitored at home for diet, glucose, sleep, and activity during observational phases. Machine learning and metabolic data, including microbiome information, may be used to explore personalized nutrition approaches to glycemic control. The study also considers how meal timing and frequency, as well as socioeconomic and lifestyle factors, influence glycemic responses. Ketone bodies, like beta-hydroxybutyrate, are explored as potential biomarkers and energy sources under varying carbohydrate availability.

Why it matters

Potential benefit: If successful, the study could inform personalized dietary strategies to improve glycemic control.

How similar studies have gone: Previous work using metabolic data and microbiome profiles has shown promise in predicting glycemic responses, supporting the potential value of this approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Overweight or obesity (BMI 25-40 kg/m²)
* Good knowledge of German

Exclusion Criteria:

* Weight changes of more than 5% in the last 3 months
* Night shift work
* Travel across more than one time zone in the last month before and during study participation
* Intensive regular physical activity of more than 2 hours per day
* Current pregnancy or breastfeeding
* Severe renal, liver or heart disease
* Existing or past hematological malignancies, other malignant tumors, unless successfully treated more than 12 months before study start
* Severe neurological or psychiatric disorders
* Daily alcohol consumption of more than 20 grams or more than 150 grams per week
* Use of illicit or legal drugs one week prior to study start and during study participation
* Known systemic infections
* Type 1 diabetes and rare forms of diabetes
* Diabetes treatment with insulin or sulfonylureas or diabetes medication in the absence of manifest type 2 diabetes
* Unstable thyroid dysfunction
* Blood coagulation disorders or anticoagulation therapy that cannot be interrupted
* Medications affecting nutrient absorption
* Medications with immunosuppressants or steroids (oral or parenteral)
* Current eating disorders, functional or structural digestive disorders or bariatric surgery
* Food allergies or intolerances to ingredients of the test meals
* Intermittent fasting or calorie-restricted diet four weeks prior to the start of the study or during the study
* Ketogenic diet or ketogenic supplements four weeks prior to or during module B
* Left-handedness
* Severe claustrophobia
* Electrical implants or non-removable metallic implants
* Concurrent participation in another intervention study
* Assessment by the study physician based on medical concerns precluding study participation

Where it's running

  • German Institute of Human Nutrition, Dept. Molecular Metabolism and Precision Nutrition and Decision Neuroscience and Nutrition
    Potsdam, Potsdam-Rehbrücke, Germany
    Recruiting

Study contacts

  • Principal investigator: Olga Ramich, Prof. Dr. — German Institute of Human Nutrition Potsdam-Rehbruecke and the Charité - Universitätsmedizin Berlin
  • Study coordinator: Olga Ramich, Prof. Dr.
  • Email: olga.ramich@dife.de
  • Phone: +49 33200 882749

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.